Tracked deals
5
5 tracked deals across 2021-2026.
Amersham, Buckinghamshire, United Kingdom
Halma is a global group of life-saving technology companies organized into three sectors: Safety, Environmental & Analysis, and Healthcare. Its purpose is to grow a safer, cleaner, healthier future for everyone, every day.
Tracked deals
5
5 tracked deals across 2021-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
3 buyout · 2 divestiture
Last 5 years
Supporting Data
Halma plc has acquired Dreampath Diagnostics, a Strasbourg-based provider of automated workflow solutions for anatomical pathology laboratories. The acquisition strengthens Halma’s Healthcare Sector, focusing on safer patient tissue sample traceability, archiving, and lifecycle management to improve diagnostics in regulated settings.
Halma plc has acquired MK Test Systems (MK Test) from private equity owner Synova in a reported £44 million deal. Synova said the sale delivers a 3x return after a decade of investment in product development, management and international expansion; MK Test is headquartered in Somerset, United Kingdom and serves aerospace, rail and electric-vehicle customers.
Halma plc has acquired FirePro, a Limassol-headquartered designer and manufacturer of condensed aerosol fire suppression systems, for €150 million on a cash- and debt-free basis. FirePro will operate as a standalone company within Halma's Safety sector, broadening Halma's fire-detection and suppression capabilities and giving FirePro access to Halma's global reach and resources.
Halma plc has acquired IZI Medical Products, an interventional radiology medical device manufacturer and distributor, from Shore Capital Partners. The deal — which closed on September 30, 2022 — brings IZI's consumable device portfolio and hospital customer base into Halma's healthcare group to expand capabilities, R&D and international growth opportunities.
Halma plc has acquired PeriGen, Inc., a Cary, North Carolina-based provider of AI-driven perinatal decision-support software. The acquisition broadens Halma’s Medical sector capabilities in advanced patient assessment and analytics; PeriGen will be managed as a standalone company. Investors Ambina Partners and Atalaya Capital, which previously backed PeriGen, sold their stakes.
Turn tracked acquisition activity into an outreach-ready buyer list.